Literature DB >> 16032381

Paraventricular nucleus, stress response, and cardiovascular disease.

Eduardo E Benarroch1.   

Abstract

The paraventricular nucleus of the hypothalamus (PVN) is a complex effector structure that initiates endocrine and autonomic responses to stress. It receives inputs from visceral receptors, circulating hormones such as angiotensin II, and limbic circuits and contains neurons that release vasopressin, activate the adrenocortical axis, and activate preganglionic sympathetic or parasympathetic outflows. The neurochemical control of the different subgroups of PVN neurons is complex. The PVN has been implicated in the pathophysiology of congestive heart failure and the metabolic syndrome.

Entities:  

Mesh:

Year:  2005        PMID: 16032381     DOI: 10.1007/s10286-005-0290-7

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  83 in total

Review 1.  Stressor specificity of central neuroendocrine responses: implications for stress-related disorders.

Authors:  K Pacák; M Palkovits
Journal:  Endocr Rev       Date:  2001-08       Impact factor: 19.871

Review 2.  Modifications to central neural circuitry during heart failure.

Authors:  M L Weiss; M J Kenney; T I Musch; K P Patel
Journal:  Acta Physiol Scand       Date:  2003-01

Review 3.  Obesity-associated hypertension: new insights into mechanisms.

Authors:  Kamal Rahmouni; Marcelo L G Correia; William G Haynes; Allyn L Mark
Journal:  Hypertension       Date:  2004-12-06       Impact factor: 10.190

4.  Superoxide mediates the actions of angiotensin II in the central nervous system.

Authors:  Matthew C Zimmerman; Eric Lazartigues; Julie A Lang; Puspha Sinnayah; Iman M Ahmad; Douglas R Spitz; Robin L Davisson
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

Review 5.  The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited.

Authors:  Mario Engelmann; Rainer Landgraf; Carsten T Wotjak
Journal:  Front Neuroendocrinol       Date:  2004 Sep-Dec       Impact factor: 8.606

Review 6.  NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy.

Authors:  S P Kalra; P S Kalra
Journal:  Neuropeptides       Date:  2004-08       Impact factor: 3.286

7.  Separate populations of neurons within the paraventricular hypothalamic nucleus of the rat project to vagal and thoracic autonomic preganglionic levels and express c-Fos protein induced by lithium chloride.

Authors:  F Portillo; M Carrasco; J J Vallo
Journal:  J Chem Neuroanat       Date:  1998-03       Impact factor: 3.052

Review 8.  Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms.

Authors:  Y-F Li; K P Patel
Journal:  Acta Physiol Scand       Date:  2003-01

9.  Melanocortin receptors mediate the excitatory effects of blood-borne murine leptin on hypothalamic paraventricular neurons in rat.

Authors:  Zhi-Hua Zhang; Robert B Felder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-02       Impact factor: 3.619

10.  Hypothalamic paraventricular nucleus inhibition decreases renal sympathetic nerve activity in hypertensive and normotensive rats.

Authors:  Asa Akine; Marisa Montanaro; Andrew M Allen
Journal:  Auton Neurosci       Date:  2003-10-31       Impact factor: 3.145

View more
  53 in total

Review 1.  Estrogen effects on the brain: actions beyond the hypothalamus via novel mechanisms.

Authors:  Bruce S McEwen; Keith T Akama; Joanna L Spencer-Segal; Teresa A Milner; Elizabeth M Waters
Journal:  Behav Neurosci       Date:  2012-02       Impact factor: 1.912

2.  Acute hypoxia activates neuroendocrine, but not presympathetic, neurons in the paraventricular nucleus of the hypothalamus: differential role of nitric oxide.

Authors:  K Max Coldren; De-Pei Li; David D Kline; Eileen M Hasser; Cheryl M Heesch
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-04-12       Impact factor: 3.619

3.  The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension.

Authors:  Carmen Capone; Giuseppe Faraco; Laibaik Park; Xian Cao; Robin L Davisson; Costantino Iadecola
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

4.  Phenotypic traits of the hypothalamic PVN cells innervating airway-related vagal preganglionic neurons.

Authors:  Prabha Kc; Abere Karibi-Ikiriko; Cheryl F Rust; Annapurni Jayam-Trouth; Musa A Haxhiu
Journal:  Respir Physiol Neurobiol       Date:  2006-03-03       Impact factor: 1.931

5.  Pathways to hypertension.

Authors:  Deborah A Scheuer
Journal:  J Physiol       Date:  2008-11-01       Impact factor: 5.182

6.  Alterations in the subcellular distribution of NADPH oxidase p47(phox) in hypothalamic paraventricular neurons following slow-pressor angiotensin II hypertension in female mice with accelerated ovarian failure.

Authors:  Tracey A Van Kempen; Ankita Narayan; Elizabeth M Waters; Jose Marques-Lopes; Costantino Iadecola; Michael J Glass; Virginia M Pickel; Teresa A Milner
Journal:  J Comp Neurol       Date:  2015-12-23       Impact factor: 3.215

7.  Sex differences in synaptic plasticity in stress-responsive brain regions following chronic variable stress.

Authors:  Eduardo F Carvalho-Netto; Brent Myers; Kenneth Jones; Matia B Solomon; James P Herman
Journal:  Physiol Behav       Date:  2011-02-17

Review 8.  Orexins and the cardiovascular events of awakening.

Authors:  Alessandro Silvani
Journal:  Temperature (Austin)       Date:  2017-02-16

9.  Mapping vocalization-related immediate early gene expression in echolocating bats.

Authors:  Christine P Schwartz; Michael S Smotherman
Journal:  Behav Brain Res       Date:  2011-06-25       Impact factor: 3.332

10.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.